Primary systemic therapy for operable breast cancer patients: the need for the new generation of trial design

被引：1
|
作者：
Alvarez, Ricardo H. [1 ]
Hortobagyi, Gabriel N. [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Dept Breast Med Oncol, Houston, TX 77030 USA
来源：
BREAST CANCER RESEARCH AND TREATMENT | 2010年 / 124卷 / 03期
关键词：
SURGICAL ADJUVANT BREAST; PREOPERATIVE CHEMOTHERAPY; NEOADJUVANT CHEMOTHERAPY; PATHOLOGICAL RESPONSE; INDUCTION CHEMOTHERAPY; PREDICTIVE MARKERS; DOXORUBICIN; SURVIVAL; WOMEN; CYCLOPHOSPHAMIDE;
D O I：
10.1007/s10549-010-1212-5
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：701 / 705
页数：5
相关论文
共 50 条
  • [31] Monitoring Primary Systemic Therapy of Large and Locally Advanced Breast Cancer by Using Sequential Positron Emission Tomography Imaging With [18F] Fluorodeoxyglucose
    Schwarz-Dose, Joerg
    Untch, Michael
    Tiling, Reinhold
    Sassen, Stefanie
    Mahner, Sven
    Kahlert, Steffen
    Harbeck, Nadia
    Lebeau, Annette
    Brenner, Winfried
    Schwaiger, Markus
    Jaenicke, Fritz
    Avril, Norbert
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (04) : 535 - 541
  • [32] FDG-PET-CT in the early response evaluation for primary systemic therapy of breast cancer
    Tokes, Timea
    Torgyik, Laszlo
    Kulka, Janina
    Borka, Katalin
    Szasz, Attila Marcell
    Toth, Andrea
    Harsanyi, Laszlo
    Lengyel, Zsolt
    Gyoerke, Tamas
    Dank, Magdolna
    CENTRAL EUROPEAN JOURNAL OF MEDICINE, 2014, 9 (02): : 306 - 312
  • [33] Role of systemic inflammatory response in predicting survival in patients with primary operable cancer
    Roxburgh, Campbell S. D.
    McMillan, Donald C.
    FUTURE ONCOLOGY, 2010, 6 (01) : 149 - 163
  • [34] Axillary treatment for operable primary breast cancer
    Bromham, Nathan
    Schmidt-Hansen, Mia
    Astin, Margaret
    Hasler, Elise
    Reed, Malcolm W.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2017, (01):
  • [35] Detection of disseminated tumor cells in locally advanced breast cancer patients before primary systemic therapy
    Sola, Montserrat
    Margeli, Mireia
    Castella, Eva
    Cirauqui, Beatriz
    Mariscal, Antonio
    Rull, Miquel
    Julian, Juan F.
    Luna, Miquel
    Vallejo, Virginia
    Fraile, Manuel
    BREAST, 2013, 22 (05) : 908 - 913
  • [36] New challenges in the field of breast cancer therapy do we need surgery for the patients with breast cancer?
    Tadashi Ikeda
    Shoshu Mitsuyama
    Breast Cancer, 2007, 14 (1) : 37 - 38
  • [37] Sentinel Lymph Node Biopsy is Precise After Primary Systemic Therapy in Stage II-III Breast Cancer Patients
    Reitsamer, Roland
    Menzel, Christian
    Glueck, Sylvia
    Rettenbacher, Lukas
    Weismann, Christian
    Hutarew, Georg
    ANNALS OF SURGICAL ONCOLOGY, 2010, 17 : S286 - S290
  • [38] Regional radiotherapy after primary systemic treatment for cN plus breast cancer patients
    Boersma, Liesbeth J.
    Mjaaland, Ingvil
    van Duijnhoven, Frederieke
    BREAST, 2023, 68 : 181 - 188
  • [39] An increase in cancer stem cell population after primary systemic therapy is a poor prognostic factor in breast cancer
    Lee, H. E.
    Kim, J. H.
    Kim, Y. J.
    Choi, S. Y.
    Kim, S-W
    Kang, E.
    Chung, I. Y.
    Kim, I. A.
    Kim, E. J.
    Choi, Y.
    Ryu, H. S.
    Park, S. Y.
    BRITISH JOURNAL OF CANCER, 2011, 104 (11) : 1730 - 1738
  • [40] Tumor reduction rate predicts early recurrence in patients with breast cancer failing to achieve complete response to primary chemotherapy
    Nagashima, Takeshi
    Sakakibara, Masahiro
    Sangai, Takafumi
    Kazama, Toshiki
    Nakatani, Yukio
    Miyazaki, Masaru
    BREAST CANCER, 2010, 17 (02) : 125 - 130
12345